Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

Delayed Data
As of Dec 01
 +0.40 / +1.27%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Enanta Pharmaceuticals Inc have a median target of 35.50, with a high estimate of 45.00 and a low estimate of 16.00. The median estimate represents a +11.29% increase from the last price of 31.90.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Enanta Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 283.90%
Growthannually -64.18%


Growthquarterly 228.24%
Growthannually -32.57%
Key to the earnings and sales forecast charts.